| Cash Flows from Operating Activities: | |
| Net income | 422.14M |
| Reconciliation of net income to cash flows from operating activities: | |
| Depreciation and amortization | 495.44M |
| Stock-based compensation | 187.03M |
| Provision for bad debts | 19.12M |
| Charge for impaired assets | |
| Gain on sale of business | |
| Gain on acquisition of business | |
| Contingent consideration expense | |
| Losses on investments in equity securities, net | |
| Equity in (income) loss on equity method investments | |
| Deferred income tax benefit | |
| Tax benefit from employee stock-based compensation | 4.76M |
| Excess tax benefit from stock-based compensation | 19.8M |
| Other | 3.77M |
| Increase (decrease) in cash from working capital changes (excluding impact of acquired assets and assumed liabilities): | |
| Accounts receivable | -336.17M |
| Inventories | -59.05M |
| Other current assets | -106.57M |
| Accounts payable, accrued expenses and deferred revenue | 444.18M |
| Cash flows from operating activities | 486.97M |
| Cash Flows from Investing Activities: | |
| Purchases of investments | -734.96M |
| Sales and maturities of investments | 418.49M |
| Purchases of equity securities | -8.01M |
| Proceeds from sales of investments in equity securities | 16.21M |
| Proceeds from sale of business | |
| Purchases of property, plant and equipment | -654.11M |
| (Investments in) distributions from equity method investment | |
| Acquisitions | |
| Purchases of other intangible assets | -18.29M |
| Other | -6.96M |
| Cash flows from investing activities | -75.34M |
| Cash Flows from Financing Activities: | |
| Proceeds from issuance of common stock | 426.52M |
| Repurchases of our common stock | -1B |
| Excess tax benefit from stock-based compensation | -19.8M |
| Proceeds from issuance of debt, net | |
| Payments of debt and capital lease obligations | -12.76M |
| Increase (decrease) in bank overdrafts | -43.89M |
| Payment of contingent consideration obligation | -131.2M |
| Other | 7.68M |
| Cash flows from financing activities | 220.92M |
| Effect of exchange rate changes on cash | -35.23M |
| Increase (decrease) in cash and cash equivalents | 597.32M |
| Cash and cash equivalents at beginning of period | 742.25M |
| Less: Cash included in assets held for sale | |
| Cash and cash equivalents at end of period | 1.33B |
| Cash paid during the year for: | |
| Interest, net of capitalized interest | |
| Income taxes | |
| In conjunction with acquisitions, we assumed the following net liabilities: | |
| Net cash paid for acquisitions and acquisition costs | |
| Contingent consideration obligations | |
| Fair value of assets acquired | |
| Gain on acquisition of business | |
| Net liabilities assumed | |